Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
new york top stories
7
×
san francisco top stories
7
×
boston blog main
boston top stories
clinical trials
new york blog main
san diego blog main
san diego top stories
san francisco blog main
fda
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
genentech
pfizer
cancer
celgene
drugs
intercept pharmaceuticals
merck
nash
nonalcoholic steatohepatitis
obeticholic acid
What
approved
7
×
drug
7
×
fda
medicine
new
bio
disease
fatty
friday
known
liver
nash
news
oral
roundup
therapy
time
adu
afternoon
agency
aimmune
allergy
alnylam
alnylam’s
approval
atrophy
awarded
beats
bids
biogen
cancer
companies
complicated
daily
data
deeper
depression
developed
digital
dire
Language
unset
Current search:
drug
×
" new york top stories "
×
approved
×
" san francisco top stories "
×
@xconomy.com
4 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
6 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug